|
The Office of Program Policy Analysis and Government Accountability (OPPAGA) is the research arm of the Florida Legislature. OPPAGA supports the Florida Legislature by providing data, evaluative research, and objective analyses that assist legislative budget and policy deliberations. State law, legislative leadership, and the Joint Legislative Auditing Committee determine OPPAGA's research issues. OPPAGA's research focuses on improving program performance, saving money, and ensuring that program activities are appropriate.〔Barrett, K., Greene, R., Patton, Z. & Keeling, J. (2005, February). (Grading the states ’05 ). (version ). ''Governing''. Retrieved March 19, 2009.〕 Since 1998, the state has saved $857 million by adopting policy options and recommendations presented in OPPAGA reports.〔Office of Program Policy Analysis and Government Accountability. (2009, March). (Fiscal impact of OPPAGA recommendations ). Tallahassee, Florida: Retrieved March 27, 2009.〕 OPPAGA operates under the guidance of a director appointed by the Joint Legislative Auditing Committee and confirmed by the House and Senate. ==History== In 1994, the Florida Legislature removed the program evaluation unit from the Florida Auditor General〔(Myflorida.com )〕 and created OPPAGA to help improve the performance and accountability of state government. Since this time, OPPAGA has provided over 1,000 reports to the Legislature.〔Office of Program Policy Analysis and Government Accountability. (n.d.). (OPPAGA Reports ). Retrieved March 27, 2009.〕 During this period, the office has received several awards for improving state government.〔Office of Program Policy Analysis and Government Accountability. (n.d.). (Professional organization awards ). Retrieved March 27, 2009.〕 *National Legislative Program Evaluation Society Excellence in Evaluation Award (2010). The criteria for the award are making a positive impact, producing a notable body of work, and furthering the field of legislative evaluation. OPPAGA also received this prestigious award in 2007, 1997, and 1989. *National Legislative Program Evaluation Society Recognition of Impact Award (2009). This award distinguishes offices that release reports documenting public policy impact within their respective states. OPPAGA has won the Impact award every year since it was first awarded in 1998. *National Legislative Program Evaluation Society Methodology Award (2009). This award recognizes projects that exemplify excellent uses of evaluation methodologies. OPPAGA also won the Methodology Award in 2007 and 2000. *Center for Accountability and Performance (CAP) Organizational Leadership Award (2001). This award recognizes an organization's outstanding application of a systems approach to performance measurement that has resulted in a culture change, sustained improvements, and demonstrated positive effects on government performance and accountability. While ''Governing'' magazine reported that OPPAGA is "one of the most impressive legislative oversight offices in the country", the office's findings and recommendations may at times be considered controversial.〔Barrett, K. & Greene, R. (2005, November). (Time for a check-up ). (Version ). ''Governing''. Retrieved March 19, 2009.〕 For example, a 2004 OPPAGA report found that a Medicaid "disease management" program the state launched in 1997 had failed to achieve its goals. Under this program, drug manufacturers received an exemption from state-mandated prescription drug discounts in exchange for providing disease management services to state Medicaid recipients with chronic conditions. OPPAGA found that the program saved the state $13.4 million, far less than the projected $108.4 million. The Florida Agency for Health Care Administration,〔(AHCA.myflorida.com )〕 which oversaw the program, and Pfizer, one of the pharmaceutical manufacturers that provided disease management, argued with the review's methodology. However, lawmakers ultimately followed OPPAGA's recommendation to separate the disease management program from the state-mandated drug discount exemptions. Now drug manufacturers can no longer provide disease management services in order to receive an exemption from state-mandated prescription drug discounts.〔Keller, A. (2008, October). (A watchdog's life ). (Version ). ''Florida Trend''. Retrieved March 19, 2009.〕 In 2011 it reported that a $108 million program to add seats to the states schools in anticipation of urgent need from 1998 to 2011, overbuilt by 25%, due to economic stagnation and subsequent lack of growth. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Office of Program Policy Analysis and Government Accountability」の詳細全文を読む スポンサード リンク
|